Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes

被引:36
作者
Ling, Zhaoli [1 ]
Shu, Nan [1 ]
Xu, Ping [1 ]
Wang, Fan [1 ]
Zhong, Zeyu [1 ]
Sun, Binbin [1 ]
Li, Feng [2 ]
Zhang, Mian [1 ]
Zhao, Kaijing [1 ]
Tang, Xiange [1 ]
Wang, Zhongjian [1 ]
Zhu, Liang [1 ]
Liu, Li [1 ]
Liu, Xiaodong [1 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China
[2] Shanxi Univ Chinese Med, Coll Chinese Pharm, Xianyang 712046, Shanxi, Peoples R China
基金
美国国家科学基金会;
关键词
Diabetes; Atorvastatin; Pregnane X receptor; Glucose transporter 2; Glucokinase; Glucose tolerance; RANDOMIZED CONTROLLED-TRIAL; COA REDUCTASE INHIBITORS; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; STATIN THERAPY; PXR; PRAVASTATIN; LIVER; METAANALYSIS; CHOLESTEROL;
D O I
10.1016/j.bcp.2015.11.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Accumulating evidences demonstrated that statins impaired glucose utilization. This study was aimed to investigate whether PXR was involved in the atorvastatin-impaired glucose utilization. Rifampicin/PCN served as PXR activator control. Glucose utilization, glucose uptake, protein levels of GLUT2, GCK, PDK2, PEPCK1 and G6Pase in HepG2 cells were measured. PXR inhibitors, PXR overexpression and PXR siRNA were applied to verify the role of PXR in atorvastatin-impaired glucose utilization in cells. Hypercholesterolemia rats induced by high fat diet feeding, orally received atorvastatin (5 and 10 mg/kg), pravastatin (10 mg/kg) for 14 days, or intraperitoneally received PCN (35 mg/kg) for 4 days. Results showed that glucose utilization was markedly inhibited by atorvastatin, simvastatin, pitavastatin, lovastatin and rifampicin. Neither rosuvastatin nor pravastatin showed the similar effect. Atorvastatin and pravastatin were selected for the following study. Atorvastatin and rifampicin significantly inhibited glucose uptake and down-regulated GLUT2 and GCK expressions. Similarly, overexpressed PXR significantly down-regulated GLUT2 and GCK expressions and impaired glucose utilization. Ketoconazole and resveratrol attenuated the impaired glucose utilization by atorvastatin and rifampicin in both parental and overexpressed PXR cells. PXR knockdown significantly up-regulated GLUT2 and GCK proteins and abolished the decreased glucose consumption and uptake by atorvastatin and rifampicin. Animal experiments showed that atorvastatin and PCN significantly elicited postprandial hyperglycemia, leading to increase in glucose AUC. Expressions of GLUT2 and GCK in rat livers were markedly down regulated by atorvastatin and PCN. In conclusion, atorvastatin impaired glucose utilization in hepatocytes via repressing GLUT2 and GCK expressions, which may be partly due to PXR activation. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / 111
页数:14
相关论文
共 50 条
[1]   Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis [J].
Baker, William L. ;
Talati, Ripple ;
White, C. Michael ;
Coleman, Craig I. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) :98-107
[2]   Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α -: Functional implications in hepatic cholesterol and glucose metabolism [J].
Bhalla, S ;
Ozalp, C ;
Fang, SS ;
Xiang, LJ ;
Kemper, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :45139-45147
[3]   Energy sensing factors PGC-1α and SIRT1 modulate PXR expression and function [J].
Buler, Marcin ;
Aatsinki, Sanna-Mari ;
Skoumal, Reka ;
Hakkola, Jukka .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (12) :2008-2015
[4]  
Collins R, 2003, LANCET, V361, P2005
[5]   Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes [J].
Feidt, Diana M. ;
Klein, Kathrin ;
Hofmann, Ute ;
Riedmaier, Stephan ;
Knobeloch, Daniel ;
Thasler, Wolfgang E. ;
Weiss, Thomas S. ;
Schwab, Matthias ;
Zanger, Ulrich M. .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) :1589-1597
[6]   Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver [J].
Ferre, T ;
Riu, E ;
Bosch, F ;
Valera, A .
FASEB JOURNAL, 1996, 10 (10) :1213-1218
[7]  
Freeman DJ, 2001, CIRCULATION, V103, P357
[8]   Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis [J].
Gotoh, Saki ;
Negishi, Masahiko .
SCIENTIFIC REPORTS, 2015, 5
[9]   Serum- and Glucocorticoid-Regulated Kinase 2 Determines Drug-Activated Pregnane X Receptor to Induce Gluconeogenesis in Human Liver Cells [J].
Gotoh, Saki ;
Negishi, Masahiko .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (01) :131-140
[10]   Role of NF-κB in regulation of PXR-mediated gene expression -: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents [J].
Gu, Xinsheng ;
Ke, Sui ;
Liu, Duan ;
Sheng, Tao ;
Thomas, Paul E. ;
Rabson, Arnold B. ;
Gallo, Michael A. ;
Xie, Wen ;
Tian, Yanan .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (26) :17882-17889